Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Feb 28;198(3):487–498. doi: 10.1007/s10549-023-06889-0

Figure 2.

Figure 2.

Pattern of dose modification of veliparib, carboplatin, and paclitaxel over time. Dose changes in veliparib, carboplatin, and paclitaxel across each dose level in dose escalation phase and in the dose expansion phase with the cycle numbers on the X axis and number of patients on the Y axis.